About the Department of
Nuclear Medicine and Theranostics
The Department of Nuclear Medicine and Theranostics is dedicated to advancing precision oncology through excellence in diagnostic imaging, targeted therapies, education, and research.
As a key pillar of the Comprehensive Cancer Center, we integrate state-of-the-art technology with clinical expertise to deliver personalized care and improved patient outcomes. Our commitment extends beyond service delivery to shaping the future of nuclear medicine through innovation and knowledge generation.
- Advanced Hybrid Imaging
State-of-the-art Dual-Head SPECT and 64-slice PET/CT systems delivering high-precision diagnostics in oncology, cardiology, neurology, and endocrinology.
- On-Site Cyclotron & Radiopharmacy
Fully equipped cyclotron and radiopharmacy facility ensuring reliable, timely, and high-quality radiotracer production.
- Integrated Theranostics Suite
Comprehensive theranostic services combining advanced molecular imaging with targeted radionuclide therapy for personalized patient care.
- Nuclear Cardiology Stress Lab
Dedicated cardiac imaging and stress testing services for accurate diagnosis, risk stratification, and management of cardiovascular disease.
- Multidisciplinary Clinical Expertise
Collaborative specialist care across oncology, endocrinology, cardiology, and neurology with high patient satisfaction, a safe clinical environment, and 24-hour report turnaround time.
- Academic & Research Excellence
Commitment to education, innovation, and AI-integrated clinical research with active academic and training programs.
Message from Our Director
Prof. Dr. Nosheen Fatima
Welcome to the Department of Nuclear Medicine and Theranostics.
It is a privilege to lead a department at the forefront of precision oncology and molecular imaging. With over two decades of clinical, research and academic experience, my vision is to establish a benchmark of excellence in Theranostics, innovation, and patient-centered care.
We integrate advanced PET/CT, hybrid molecular diagnostics, and targeted radionuclide therapies to deliver personalized, high-impact care. Alongside clinical excellence, we are committed to education, hands-on training, and fostering a culture of inquiry and collaboration.
Our strategy is firmly aligned with internationally recognized quality standards and accreditation frameworks, ensuring safety, consistency, and continuous improvement. We are also advancing AI-integrated research and translational collaborations to improve cancer outcomes, particularly within our population.
Aligned with the vision of DUHS, we are building a future-ready department focused on infrastructure development, service expansion, academic excellence, and equitable access to advanced care.
We remain committed to transforming care, advancing science, and improving lives, redefining precision oncology through innovation, leadership, and impact.
Inauguration of Department
We extend our deepest gratitude to Chief Minister Sindh, Mr. Murad Ali Shah, for gracing the inauguration ceremony of our Nuclear Medicine and Theranostics Department. His presence underscores the government’s commitment to advancing healthcare in Sindh. We also sincerely thank Prof. Saeed Qureshi, our esteemed former Vice Chancellor, for his visionary leadership in making this department a reality, further solidifying our institution’s reputation for excellence in medical education and research.
Our History
For many years, Dow University of Health Sciences (DUHS) has been a beacon of hope for cancer patients, providing state-of-the-art treatment options aimed at improving patient outcomes. The university’s unwavering commitment to this cause reached an important milestone with the inauguration of the Comprehensive Cancer Centre on April 16, 2025. This visionary project initiated by Professor Dr. Muhammad Saeed Quraishy (TI) former Vice Chancellor of DUHS, aims to deliver advanced cancer care that is both high-quality and affordable, housed under one roof to ensure accessibility for all.
The journey towards this goal began earnestly in October 2021 with the establishment of Pakistan’s first public sector Gamma Knife Radiosurgery unit. This was a pioneering step, marking DUHS’s commitment to adopting cutting-edge technologies for cancer treatment. In November 2022, the foundation stone was laid for the extension of civil work dedicated to the Comprehensive Cancer Centre, setting the stage for a holistic approach to cancer care.
The Comprehensive Cancer Centre itself is a meticulously designed ground plus two-story building. The ground floor hosts three major departments: Gamma Knife Stereotactic Radiosurgery with on-site MRI for precise planning, Radiation Therapy department equipped with Pakistan’s first MR- LINAC for precise radiation treatment of various cancers, and the newly launched Nuclear Medicine and Theranostics department. The first floor accommodates the Medical Oncology department, which is bolstered by an onco-pharmacy and surgical-oncology clinics. The second floor houses a large auditorium designated for in-house academic activities, underlining the university’s commitment to continuous learning and innovation.
Statement of Purpose
The Department of Nuclear Medicine and Theranostics is committed to advancing precision oncology through excellence in diagnostic imaging, targeted radionuclide therapy, education, and research.
Aligned with DUHS’s vision of transforming and saving lives, we deliver patient-centered care supported by cutting-edge technology and innovation. As part of the Comprehensive Cancer Center, we strive to be a nationally recognized hub of excellence in molecular imaging and Theranostics.
Our 2026–2029 strategic focus includes strengthening infrastructure, expanding clinical services, advancing academic programs, and promoting impactful research-while ensuring equitable access to high-quality nuclear medicine care.
Our
Vision
To be a leading center of excellence in Nuclear Medicine and Theranostics, advancing precision healthcare and improving lives through innovation, education, and research.
Our
Mission
- Deliver high-quality, patient-centered diagnostic and therapeutic nuclear medicine services
- Advance precision oncology through integrated Theranostics
- Provide outstanding education and training for future healthcare professionals
- Foster impactful, translational research and innovation
- Ensure equitable access to advanced molecular imaging and therapy
NMT Hero
Faculty
Technical Team
Supportive Team
Our Services
- Brain Scan (cerebral perfusion)
- Bone scan (whole body)
- Hepatobiliary imaging (HIDA scan)
- I-131 whole Body scan
- I-131 Whole Body MIBG scan
- Lymphoscintigraphy
- Lung perfusion scan
- Lung shunt fraction (LSF) study
- Meckel’s scan
- Octreotide scan (HYNIC-SPECT)
- Parathyroid scan
- RBC’s scan
- Renal scan (MAG-3/DTPA)
- Renal scan Captopril Study
- Renal cortical scan (DMSA scan)
- Sentinel Lymph Node Mapping
- Thyroid scan
- F18-FDG PET/CT
- F18- Na-PET/CT (opening soon)
- F18-PSMA PET/CT
- F18- FAPI PET/CT (opening soon)
- F18 MISO-PET/CT (opening soon)
- F18- FCH (Fluro Choline) PET/CT (opening soon)
- F18-FET (Fluro Ethylene-L-Tyrosine) PET/CT (opening soon)
- F18- FLT (Fluro Thymidine) PET/CT (opening soon)
- F-18 NOTA (OCTREOTIDE) PET/CT
- Myocardial Perfusion imaging (SPECT) with Stress
- Myocardial Rest Viability (SPECT) with Nitrate
- MUGA scan for LVEF
- Myocardial Perfusion imaging (PET) with Stress (opening soon)
- Cardiac PET Viability (opening soon)
- Cardiac PET Sarcoidosis (opening soon)
- Out-patient-I-131 Therapy (less than 30 mCi)
- In-patient I-131 Therapy (more than 30 mCi)
- In-patient I-131 MIBG Therapy
- Out-patient Lu-177 therapy
- TARE – Transarterial Radioembolization (On Consultation)
Our Strategic Focus (2026–2029)
- Strengthening Infrastructure & Technology
Advancing imaging systems, cyclotron and radio pharmacy capabilities, and Theranostic facilities to support high-quality care - Expanding Clinical & Theranostic Services
Broadening SPECT, PET/CT, nuclear cardiology, and targeted radionuclide therapy services - Enhancing Academic & Training Programs
Developing structured education and hands-on training to cultivate future healthcare leaders - Promoting High-Impact Research & Innovation
Advancing translational and AI-integrated research to improve clinical outcomes and precision medicine - Quality, Accreditation & Global Benchmarking
Aligning with national and international accreditation standards to ensure excellence, safety, and continuous quality improvement - Improving Accessibility & Service Equity
Expanding access to advanced nuclear medicine services while ensuring patient-centered, equitable care
NMT Organogram
Picture Gallery
